Population‐based drug‐related anaphylaxis in children and adolescents captured by South Carolina Emergency Room Hospital Discharge Database (SCERHDD) (2000–2002)
- 8 October 2007
- journal article
- research article
- Published by Wiley in Pharmacoepidemiology and Drug Safety
- Vol. 16 (12), 1255-1267
- https://doi.org/10.1002/pds.1502
Abstract
Purpose Anaphylaxis is a life-threatening condition; drug-related anaphylaxis represents approximately 10% of all cases. We assessed the utility of a statewide emergency department (ED) database for identifying drug-related anaphylaxis in children by developing and validating an algorithm composed of ICD-9-CM codes. Methods There were 1 314 760 visits to South Carolina (SC) emergency departments (EDs) for patients <19 years in 2000–2002. We used ICD-9-CM disease or external cause of injury codes (E-codes) that suggested drug-related anaphylaxis or a severe drug-related allergic reaction. We found 50 cases classifiable as probable or possible drug-related anaphylaxis and 13 as drug-related allergic reactions. We used clinical evaluation by two pediatricians as the ‘alloyed gold standard’ 1 for estimating sensitivity, specificity, and positive predictive value (PPV) of our algorithm. Results ED-treated drug-related anaphylaxis in the SC pediatric population was 1.56/100 000 person-years based on the algorithm and 0.50/100 000 person-years based on clinical evaluation. Assuming the disease codes we used identified all potential anaphylaxis cases in the database, the sensitivity was 1.00 (95%CI: 0.79, 1.00), specificity was 0.28 (95%CI: 0.16, 0.43), and the PPV was 0.32 (0.20, 0.47) for the algorithm. Sensitivity analyses improved the measurement properties of the algorithm. Conclusions E-codes were invaluable for developing an anaphylaxis algorithm although the frequently used code of E947.9 was often incorrectly applied. We believe that our algorithm may have over-ascertained drug-related anaphylaxis patients seen in an ED, but the clinical evaluation may have under-represented this diagnosis due to limited information on the offending agent in the abstracted ED records. Post-marketing drug surveillance using ED records may be viable if clinicians were to document drug-related anaphylaxis in the charts so that billing codes could be assigned properly. Copyright © 2007 John Wiley & Sons, Ltd.Keywords
This publication has 15 references indexed in Scilit:
- Second symposium on the definition and management of anaphylaxis: Summary report—Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposiumJournal of Allergy and Clinical Immunology, 2006
- AnaphylaxisMedical Clinics of North America, 2006
- Paediatric emergency department anaphylaxis: different patterns from adultsArchives of Disease in Childhood, 2005
- Anaphylaxis presentations to an emergency department in Hong Kong: Incidence and predictors of biphasic reactionsThe Journal of Emergency Medicine, 2005
- Epidemiology of anaphylaxis among children and adolescents enrolled in a health maintenance organizationJournal of Allergy and Clinical Immunology, 2004
- Detecting Adverse Events Using Information TechnologyJournal of the American Medical Informatics Association, 2003
- Emergency department anaphylaxis: A review of 142 patients in a single yearJournal of Allergy and Clinical Immunology, 2001
- Anaphylaxis in the United StatesArchives of Internal Medicine, 2001
- Epidemiology of anaphylaxis in Olmsted County: A population-based study☆☆☆★★★Journal of Allergy and Clinical Immunology, 1999
- Drug-related fatal anaphylactic shock in Denmark 1968–1990. A study based on notifications to the Committee on Adverse Drug ReactionsJournal of Clinical Epidemiology, 1995